Related Experiment Videos
Herpes simplex viruses 1 and 2
Kimberly A Yeung-Yue1, Mathijs H Brentjens, Patricia C Lee
1Departments of Dermatology, Microbiology/Immunology, and Internal Medicine, University of Texas Medical Branch-Galveston, Galveston, TX 77555, USA.
Dermatologic Clinics
|July 18, 2002
Summary
Effective treatments for herpes simplex virus (HSV) infections are advancing, with new drugs and vaccines showing promise in reducing severity and frequency of outbreaks.
Area of Science:
- Virology
- Infectious Diseases
- Pharmacology
Background:
- Herpes simplex virus (HSV) infections pose significant public health challenges.
- Understanding HSV pathogenesis and transmission has improved diagnostic and therapeutic approaches.
Purpose of the Study:
- To review current and emerging treatment strategies for HSV infections.
- To highlight advancements in managing both typical and atypical HSV presentations.
Main Methods:
- Literature review of recent research on HSV treatment.
- Analysis of novel prophylactic and therapeutic antiviral regimens.
- Exploration of vaccine development for HSV.
Main Results:
- Effective antiviral drug regimens are available, with ongoing research for optimal use.
- Atypical HSV presentations can be managed with newer agents like cidofovir gel.
- Emerging treatments like resiquimod may modify HSV infection course, reducing recurrence.
Conclusions:
- Continued research is vital for optimizing HSV treatment regimens.
- Novel therapeutic agents and vaccines offer promising future strategies for HSV control.
- Advances in diagnostics and understanding of HSV are driving improved patient outcomes.